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ABSTRACT 
Kidneys are the organs that have numerous biological roles in maintaining the 
homeostatic balance of body fluids by removing wastes out of the body. Chronic Kidney 
Disease (CKD) has always remained a major area of concern since a long time as it leads 
to irreversible deterioration in renal function which classically develops over a period of 
years. CKD is considered when glomerular filtration rate (GFR) falls below 30 ml/min. 
The conventional approach of management includes dialysis and renal transplantation, 
which are not easily affordable. If still can afford it, these costs have to be borne for life 
time and where in the complication problems after a transplant may include post-
operative complication, bleeding, infection, vascular thrombosis and transplant rejection. 
Therefore, exploration of a safe and alternative therapy is needed, which proves to be 
helpful in reducing the requirement of dialysis and in postponing the renal 
transplantation. Ayurveda highlights the significance of Trimarma viz., Sira, Hrudaya, and 
Basti which are to be protected, if not may lead to many trivial diseases and may turn 
fatal. Though Basti Marma is identified structurally as bladder, the entire functional 
aspect of renal system is to be considered among which functioning of Kidneys occupies 
the major place. If we consider CKD as the disease affecting Basti Marma, then Basti 
Karma can be adopted as the treatment of choice as it is told to be best for Marma 
Paripalana. In this regard, a study was designed to manage the conditions of chronic 
kidney disease with Triphaladi Niruha Basti administered in Kala basti pattern along 
with Shamana Aushadis. The study revealed that there is marked improvement in 
reducing the clinical and laboratory manifestations of CKD. 
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INTRODUCTION 
Chronic Kidney Disease (CKD) is 
progressive loss in renal function over a period 
of months or years. It is a multi factorial 
condition that results in destruction of normal 
structure and initiating abnormality in normal 
function of kidney. CKD is considered as one of 
the life threatening condition and the associated 
rising treatment cost leave normal life crippling. 
CKD lead for morbidity if the proper treatment is 
not extended in the right time. Initially, renal 
disorders involving kidney malfunction, is 
manifested only as a biochemical abnormality. 
Eventually without proper treatment & follow 
up loss of the excretory, metabolic and 
endocrine functions of the kidney leads to the 
development of the clinical symptoms and signs 
of renal failure. When death is likely without 
Renal Replacement Therapy (RRT), it is called 
End Stage Renal Failure (ESRF).1 Chronic Kidney 
Disease is diagnosed by elevated serum 
creatinine and blood urea & nitrogen. In 
Ayurveda, Vrikka-Vikara may be considered as an 
end stage induced by Prameha, where the urine 
becomes turbid. It is expressed that, the 
turbidity of Mutra (urine output) is because of 
the infiltration of the Prameha`s - Dushya`s which 
include Medo-Rakta-Mamsa-Majja-Shukra-
Udaka, Rasa, Lasika, Oja.2 It means that higher 
destruction and involvement of these Dushya 
lead to development of turbid urine (Avila-
mutrata). In agreement of the above statement, 
should we go through the contemporary 
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literatures, it has been noted that higher levels of 
creatinine indicate a lower glomerular filtration 
rate and as a result a decreased capability of the 
kidneys to excrete waste products. Creatinine 
levels may be normal in the early stages of CKD 
and the condition is discovered if urinalysis 
shows that the kidney allowing the loss of 
protein or red blood cells into the urine. The 
prevalence rate of CKD in India ranges from 
0.79% to 1.4% and the incidence rate of end 
stage renal disease was estimated to be 181 per 
million population in 2005.3 The treatment of 
Chronic Kidney Disorders consists of treatment 
of the underlying cause if possible, but with 
progressive end-stage disease, restoration of 
kidney function can only be possible with 
dialysis or a kidney transplant. So, the economic 
consequences of CKD are very costly and may 
not be easily affordable by all. Hence forth, a safe 
treatment approach is required to be explored 
for the better management of CKD. In Ayurveda, 
Shiras, Hrudaya and Basti are identified as 
Trimarma. Basti marma has to be understood by 
structural as well as functional aspect of entire 
renal system which is hampered in CKD So, for 
the treatment of Marma, Tasmana bastisamama 
kinchitta karma marmaparipalanamasti,4 there 
is nothing better than Basti Karma also 
highlights the same. 
Aims and Objectives 
 To evaluate the efficacy of the Triphaladi 
niruha basti and Shamana aushadi in the 
management of Chronic Kidney Disease. 
 To evaluate safety of the Triphaladi niruha 
basti and Shamana aushadi in the 
management of Chronic Kidney Disease. 
MATERIALS AND METHODS 
This study started after enrolment of 
patients attending the OPD of Dept of 
Panchakarma at SKAMC Hospital & Research 
center Bangalore by follow up the protocol, with 
post-acceptance of the consent from as per the 
protocol approved in IEC. In this study, 10 
diagnosed patients of CKD were selected based 
on purposive sampling technique. 
In this study, patients were administered 
with Triphaladi Niruha Basti (Anubhuta yoga) 
and Shamana Aushadhi (Veerataradi kashayam,5 
Varunadi kashayam,6 Bringarajasava,7 
Pippalayasa8). The above mentioned 
formulations are purchased from different 
approved pharmaceutical companies. The 
subjective and objective parameters were 
assessed before the treatment and after the 
treatment. The data obtained were recorded, 
tabulated and statistically analysed by using 
paired ‘t’ test. 
HYPOTHESIS 
Ho - There is no significant therapeutic 
effect of Triphaladi Niruha Basti and Shamana 
Aushadi in the management of Chronic Kidney 
Disease. 
H1 - There is significant therapeutic effect of 
Triphaladi Niruha Basti and Shamana Aushadi in 
the management of Chronic Kidney Disease. 
SOURCE OF DATA  
 Ten diagnosed patients of Chronic Kidney 
Disease following inclusion criteria 
approaching the OPD and IPD of 
SKAMCH&RC, Bangalore were selected for 
the study. 
 Secondary data from text book, refer 
journal Peer reviewed text etc. 
DIAGNOSTIC CRITERIA 
 Diagnosed cases of CKD were taken for the 
study. 
 Patients presenting with the Signs and 
Symptoms of CKD viz. 
Table no .1 
Tiredness Nausea 
Breathlessness Vomiting 
Anorexia Pedal edema 
 Patients presenting with elevated levels 
of serum creatinine (0.68 – 1.36mg/dl).9 
 Patients presenting with elevated levels 
of blood urea (15 – 40mg/dl).10 
 Patients presenting with stage 1, stage 2, 
and stage 3, grade of Chronic Kidney 
Disease with GFR ranging from ≥ 90 to 
30-59.11 
INCLUSION CRITERIA 
 Either sex in between the age group of 16 
yrs to 70 yrs. 
 Diagnosed as CKD. 
 Patient suitable for Basti Karma. 
EXCLUSION CRITERIA 
 Major systemic diseases that may interfere 
the course of treatment such as 
uncontrolled Diabetic mellitus and 
Hypertension, refractive disorder, G6PD 
deficiency, Artificial pace maker or such 
other conditions that interferes the renal 
function. 
 Requiring dialysis and renal transplant. 
 End stage of Chronic Kidney Disease i.e., 
stage 4 and stage 5. 
STUDY DESIGN 
Open level randomized continuous linear study. 
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INTERVENTION 
All the selected patients after proper 
evaluation were administered with Triphaladi 
Niruha Basti along with Shamana aushadi for a 
period of 15 consecutive days. 
Post-test investigation was done on the 16th day 
of treatment. 
Basti was administered in the pattern of Kala 
Basti where in Anuvasana Basti was 
administered in the beginning followed by three 
conjugative Niruha Basti again Anuvasana Basti 
was administered. In the similar manner Nine 
Niruha Basti’s and six Anuvasana Basti 
administered considering the Kapha dosha 
dominance. 
 
Ingredients: 
Procedure  
Poorva karma: Sarvanga abhyanga with 
Triphaladi Taila followed by Mridu Bashpa 
Sweda was done for a duration of 40 minutes.  
Pradhana karma 
 Basti karma was preformed as per the 
classical reference. 
 Triphaladi niruha basti was administered in 
empty stomach in the early morning. 
 Anuvasana Basti was administered using the 
Triphaladi taila in the dosage of 80ml after 
the intake of food. 
Pashchat Karma: Lift the legs, patting to the 
buttocks, anti-clockwise massage to abdomen. 
Shamana Aushadi’s  
Veerataradi kashayam     2 teaspoon each with 
 Varunadi kashayam           Equal quantity of    
Bringarajasava                   water thrice daily after    
Pippalayasava                     food   
Assessment criteria 
The following subjective and objective 
parameters were clinically assessed before and 
after treatment and the results were statistically 
analyzed and presented in a tabular form. 
Parameters 
Subjective Parameters 
1. Tiredness 
2. Breathlessness 
3. Anorexia 
4. Nausea 
 
 
Objective Parameters 
1. Serum creatinine 
2. Blood urea 
3. GFR 
4. Pedal edema 
1. Tiredness  Score 
No tiredness : 0 
Occasional feeling of tiredness on 
light activity 
: 1 
Constant feeling of tiredness on 
heavy activity 
: 2 
Feeling tiredness all the time : 3 
2. Breathlessness  Score 
No breathlessness : 0 
Breathlessness on upstairs /quick 
moving 
: 1 
Breathlessness on light physical 
work 
: 2 
Breathlessness on bed : 3 
3. Anorexia  Score 
Takes full diet and also presence 
of proper appetite at the next 
meal hour 
: 
    0 
Presence of moderate appetite 
and proper appearance of 
appetite in next meal hour 
: 
    1 
Presence of moderate appetite 
but delayed appearance of 
appetite in next meal hour 
: 
    2 
Presence of low appetite and 
delayed appearance of appetite in 
next meal hour 
: 
    3 
4. Nausea  Score 
No nausea : 0 
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Schedule A N N N A N N N A N N N A A A 
Table no 2: showing the ingredients of Triphaladi basti 
Triphaladi niruha basti Triphaladi anuvasana basti 
Madhu 30ml Anuvasana basti Triphaladi taila 80 ml 
Saindava lavana 10gm 
 
Triphaladi taila 80ml 
Katuki & Madanaphala churna 20gm each 
Triphala qwatha 350ml 
Total quantity 490ml 80 ml 
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Less than 2 times : 1 
2-5Times : 2 
> 5 times : 3 
1. Pedal Edema  Score 
No edema : 0 
Slight pitting 2mm, disappears : 1 
rapidly 
Deep pitting 4mm, disappears in 
10-15secs 
: 
2 
Deeper pitting 6mm, may last > 1 
min 
: 
3 
Table 3: Assessment of results in Subjective parameters 
Pts. Name Tiredness Breathlessness Anorexia Nausea 
 BT AT BT AT BT AT BT AT 
a.  3 2 3 2 3 2 1 1 
b.  3 1 3 1 3 3 1 0 
c.  2 1 3 1 2 1 1 0 
d.  2 1 2 1 0 0 2 1 
e.  2 0 1 0 2 0 2 1 
f.  2 1 2 1 2 1 1 0 
g.  3 2 1 0 0 0 1 0 
h.  0 0 0 0 0 0 0 0 
i.  0 0 0 0 1 1 0 0 
j.  0 0 2 2 1 0 0 0 
Table 4: Assessment of results in Objective parameters 
Pts. Name Serum creatinine Blood urea GFR Pedal Edema 
 BT AT BT AT BT AT BT AT 
a.  1.7 mg/dl 1.3 mg/dl 55 mg/dl 37 mg/dl 32 44 2 0 
b.  5.9 mg/dl 5.4 mg/dl 106 mg/dl 58 mg/dl 10 11 3 2 
c.  5 mg/dl 3.2 mg/dl 66 mg/dl 60 mg/dl 12 20 2 1 
d.  1.6 mg/dl 0.8 mg/dl 52.7 mg/dl 34 mg/dl 46 102 3 2 
e.  7.4 mg/dl 7.6 mg/dl 120 mg/dl 133 mg/dl 7 7 2 1 
f.  1.5 mg/dl 1.1 mg/dl 58 mg/dl 32 mg/dl 49 70 3 1 
g.  5.6 mg/dl 5.2 mg/dl 110 mg/dl 52 mg/dl 11 12 3 2 
h.  5.2 mg/dl 3.2 mg/dl 60 mg/dl 56 mg/dl 9 15 3 2 
i.  7.2 mg/dl 7.4 mg/dl 118 mg/dl 130 mg/dl 8 8 2 2 
j.  1.2 mg/dl 0.9 mg/dl 58 mg/dl 32 mg/dl 46 65 3 1 
 
 
Table 5: Statistical values showing the effect on Subjective Parameter 
Tiredness 
Group 
Mean 
Mean diff. 
Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 1.7 0.8 0 3.85 0.003 
Breathlessness 
Group 
Mean 
Mean diff. 
Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 1.7 0.8 0 3.85 0.003 
Anorexia 
Group 
Mean 
Mean diff. 
Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 1.4 0.8 0 2.7 0.02 
Nausea 
Group 
Mean 
Mean diff. 
Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 0.9 0.3 0 3.6 0.05 
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Observations and Results 
In this study, all the patients were in the 
age group of 32 yrs to 58yrs. However, the 
majority (60%) of the patients were male 
between 32 yrs to 58 years of age. All the 
patients after proper review of their health 
condition and after satisfactory examination 
pertaining to inclusion and exclusion criteria 
are being included in this study following the 
protocol approved in the institutional ethical 
committee. The subjective parameters have 
taken for assessment of the symptomatic relief 
which confirms the regression of the 
pathological condition. Patients are reported 
with lesser impact on tiredness as compared to 
pre-treatment & post-treatment, which has 
shown statistical significance with p-value 0.03, 
other features like breathlessness, anorexia and 
nausea have shown their impact when 
compared between pre & post-treatment 
conditions which has shown statistically 
significant impact with p - scores as 0.03, 0.02, 
0.05, respectively. Three parameters that 
include serum creatinine and blood urea and 
GFR have shown equal response to the 
treatment and equally share the satisfactory 
statistical score i.e., the p–value, 0.02, 0.03, 0.04, 
respectively. Rest one parameter that includes 
pedal edema has shown response to the 
treatment and share the statistical score p -
value 0.01. 
DISCUSSION 
Chronic Kidney Disease (CKD) is 
progressive loss in renal function over a period 
of months or years and is caused by any 
condition which destroys the normal structure 
as well as function of the kidney. CKD is 
considered when glomerular filtration rate 
(GFR) falls below 30 ml/min. A person can lead 
to uremia when CKD is not managed properly 
and represented with loss of the excretory, 
metabolic and endocrine functions. Higher 
levels of creatinine indicate a lower glomerular 
filtration rate and as a result a decreased 
capability of the kidneys to excrete waste 
products. Creatinine levels may be normal in 
the early stages of CKD and the condition is 
discovered if urinalysis shows that the kidney 
allowing the loss of protein or red blood cells 
into the urine. In Ayurveda, the etiopathogenesis 
of Prameha gives an idea regarding 
pathogenesis of Chronic Kidney Disease (CKD). 
The affliction of Rasa, Rakta, Mamsa, Meda & 
Kleda in Prameha can be viewed in Chronic 
Kidney Disease (CKD) in terms of proteinurea, 
elevated level of blood urea and Serum 
creatinine and involvement of Vata vitiating the 
bodily tissues which have the predominance of 
Kapha dusti has to be managed by adopting 
Teekshana Basti where in the procedural action 
of Basti acts on Vata and Teekshanatha of Basti 
counteracts vitiated Kapha. Triphaladi Niruha 
Basti along with various Shamana aushadhi’s as 
mentioned in the methods and materials are 
used in this study has shown an encouraging 
result in minimizing the clinical symptoms of 
the CKD. Triphaladi Niruha Basti enriched with 
Madhu that contains various enzyme extend 
anti-inflammatory and anti bacterial activities 
which are helpful in reducing the symptoms of 
CKD. Saindhava, because of Suksma and Visyandi 
Table 6:  Statistical values showing the effect on Subjective Parameter 
Serum creatinine 
Group Mean Mean diff. Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 4.23 3.61 0 2.64 0.02 
 
Blood urea 
Group Mean Mean diff. Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 80.37 62.4 0 2.4 0.03 
GFR 
Group Mean Mean diff. Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 23 35.4 0 2.28 0.04 
Pedal edema 
Group Mean Mean diff. Paired ‘t ’ test 
Before After ‘t’ P 
BT-AT 2.6 1.4 0 6 0.01 
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properties, possibly help to transport the drug 
molecules in the systemic circulation through 
mucosa. It is also capable of liquefying the viscid 
matter and breaking it into minute particles and 
helping in Dosha vilayana. In addition to that, 
Saindhava lavana helps in removal of Doshas by 
its Lekhana property. Triphala is rich source of 
galic acid and tannins exhibits anti oxidant, anti 
inflammatory and detoxification activities. 
Triphala has antioxidant, rejuvenating 
(Rasayana property), Tridoshahara, and 
Amapachaka action which help in rejuvenating 
of damaged capillaries apart from removal of 
atherosclerosis, improve circulation and GFR. 
Katuki & Madanaphala help to bring collective 
benefits for its Pitta rechaka and Kaphara hara 
action. Triphaladi Niruha Basti is considered as 
Teekshana basti because, which has a counter-
pharmacological action of vitiated Kapha dosha. 
Varunadi Kashayam with enriched source of 
tannin from Varuna (Crateva nurvulla) extends 
a lithontriptic, nephroprotective and diuretic 
activity, and in return is responsible for 
promoting the GFR and relieving from CKD. 
Bhringaraja (Eclipta alba) present in 
Bringarajasava with the presence of flavonioids 
extend anti oxidant, anti-inflammatory and anti 
microbial activity and thus extends chronic non 
specific UTI associated with CKD. Pippali (Piper 
longum) present in Pippalayasava are subjected 
to enhance the bio availability, and thus 
allowing faster penetration of the phyto-
molecules because of piperine. Piperine is 
helpful in improving capillary permeability 
which can improve intra or inter cellular 
transportations. Veerataradi Kashayam 
containing Pashanabheda (Bergenia ligulata), 
Rambha (Musa peridisica), Gokshura (Tribulus 
terrestris) and along with Mutrala (diuretic) 
ingredients extend the beneficial activity in 
combating the clinical features of CKD. 
CONCLUSION 
Basti used in the present study is very 
much effective in improving the kidney 
functions and the Basti used in this study having 
the property of Sroto vishuddhi. The kidneys are 
made up of principally the “Rakta” and “Meda” 
dhatus. Every physician will address to maintain 
the imbalance between these two Dhatus by 
using proper Basti karma and shamanaushadhis. 
In this research study, we have used Triphaladi 
Niruha Basti along with various Shamana 
aushadhi, has resulted in the reversal of the 
kidney factors and recover from CKD. This 
action may be tribute to its various Sothagna 
(Anti-inflammatory), Mutrala (Diuretic), 
Lekhana (Scrapes). This treatment approach is a 
safe and effective in case of CKD, further studies 
to be conducted in a large sample to establish 
the facts with more statistical and scientific 
strength. 
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